Hospital
University of South Alabama
University of South Alabama was paid $4.62M by Medicaid between Jan 2018 and Dec 2024, across 83 billing codes. Its largest line is 99284, emergency room visit (serious) — 21% of everything it billed.
33Billing provider infoUNIVERSITY OF SOUTH ALABAMA
MOBILE, AL 36617
MOBILE, AL 36617
33aNPI1063468072assigned 05/25/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.62M
24GClaims148,079
24DCodes billed83
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Alabama
Rank by total paid#15 of 77
Median peer was paid$1.13M
This provider vs. median4.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,269 | $271K | |
| 2019 | 14,665 | $481K | |
| 2020 | 6,004 | $111K | |
| 2021 | 12,060 | $315K | |
| 2022 | 30,252 | $891K | |
| 2023 | 43,795 | $1.62M | |
| 2024incomplete | 27,034 | $934K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 13,733 | 12,716 | $949K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 20% | 3,530 | 3,135 | $923K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 15,118 | 14,171 | $653K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7.6% | 7,437 | 7,105 | $353K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 6.4% | 7,485 | 6,071 | $298K |
| 80053 | Comprehensive metabolic panel | 5.0% | 22,516 | 18,618 | $233K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.6% | 25,737 | 20,807 | $213K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4.3% | 3,154 | 3,040 | $197K |
| J9312 | Injection, rituximab, 10 mg | 3.1% | 16 | 12 | $143K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.9% | 7,247 | 6,519 | $88K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.8% | 1,119 | 597 | $82K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.2% | 1,465 | 1,414 | $57K |
71 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.0% | 1,035 | $46K |
| 97602 | <1% | 1,773 | $43K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 246 | $42K |
| 81001 | <1% | 8,551 | $37K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 331 | $29K |
| 87400 | <1% | 2,146 | $27K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,969 | $22K |
| 84484 | <1% | 1,357 | $17K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 797 | $17K |
| 87088 | <1% | 1,645 | $16K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 513 | $15K |
| 87430 | <1% | 770 | $15K | |
| 87634 | <1% | 195 | $12K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 111 | $9K |
| 81025 | <1% | 2,282 | $8K | |
| 83735 | <1% | 1,272 | $8K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,168 | $8K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,630 | $8K |
| 83605 | <1% | 747 | $6K | |
| 83690 | <1% | 762 | $6K | |
| 87081 | <1% | 398 | $5K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 50 | $3K |
| 87420 | <1% | 170 | $3K | |
| 85610 | <1% | 1,028 | $3K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 13 | $3K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 16 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 34 | $3K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 41 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 223 | $2K |
| 86900 | <1% | 83 | $2K | |
| 96415 | <1% | 38 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,223 | $2K |
| 82553 | <1% | 122 | $1K | |
| 86850 | <1% | 83 | $1K | |
| 82550 | <1% | 143 | $816.00 | |
| 86901 | <1% | 84 | $724.04 | |
| 86300 | <1% | 39 | $629.20 | |
| 85730 | <1% | 270 | $602.95 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 146 | $515.34 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 91 | $504.69 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 464 | $461.52 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 270 | $364.59 |
| 85027 | <1% | 121 | $355.02 | |
| 82962 | <1% | 1,349 | $329.45 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 568 | $304.05 |
| 84703 | <1% | 46 | $281.26 | |
| 87077 | <1% | 145 | $279.40 | |
| 73130 | <1% | 21 | $242.25 | |
| 73630 | <1% | 12 | $200.10 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 821 | $178.58 |
| 83615 | <1% | 34 | $168.00 | |
| 85379 | <1% | 17 | $148.20 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 50 | $129.81 |
| 87070 | <1% | 13 | $111.93 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 57 | $72.75 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 78 | $55.94 |
| 87205 | <1% | 13 | $49.63 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 16 | $18.75 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 14 | $12.72 |
| 87186 | <1% | 106 | $10.44 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 64 | $5.48 |
| J2704 | Injection, propofol, 10 mg | <1% | 178 | $2.60 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 98 | $0.72 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 40 | $0.52 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 192 | $0.02 |
| 85018 | 0% | 19 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 27 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 15 | $0.00 |
| A6209 | Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 0% | 21 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 39 | $0.00 |
| 85014 | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROBERTS, KRISTEN (VP OF FINANCE)
| Provider | Location | Paid |
|---|---|---|
| University of South Alabama | Mobile, AL | $24.82M |
| University of South Alabama | Mobile, AL | $4.61M |
| USA Health Anesthesia Billing Services, LLC | Mobile, AL | $1.91M |
| USA Health Hca Providence Hospital LLC | Mobile, AL | $357K |
| Childhood Educational Associates, LLC | Schenectady, NY | $68K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.